Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why President Elect Joe Biden Chose to Take a Weight Bearing CT Scan of His Foot

President-elect Joe Biden’s physician recommended he get a weight bearing CT scan to monitor the healing progression of a sustained hairline fracture, according to an AP report. President-elect Joe Biden’s medical visit to Philadelphia made headlines over the weekend after his physician recommended he receive a “special” weight bearing CT scan. Biden visited Pennsylvania Hospital, a Penn…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Why President Elect Joe Biden Chose to Take a Weight Bearing CT Scan of His Foot

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

President-elect Joe Biden’s physician recommended he get a weight bearing CT scan to monitor the healing progression of a sustained hairline fracture, according to an AP report.

President-elect Joe Biden’s medical visit to Philadelphia made headlines over the weekend after his physician recommended he receive a “special” weight bearing CT scan. Biden visited Pennsylvania Hospital, a Penn Medicine facility, to obtain the imaging exam.

Pennsylvania Hospital utilizes the CurveBeam pedCAT weight bearing CT system.

Dr. Kevin O’Connor, of the GW Medical Associates, said in statement Saturday morning ahead of the appointment. “Consistent with our original plan, President-elect Biden will receive routine 2-week post-injury imaging today. This will be performed with a special CT scanner which is able to obtain a ‘weight-bearing’ image. Now that the initial discomfort and swelling are decreased, it is important to observe the structures within the mid foot under the actual pressure of standing. This is the best way to assure ankle and foot stability.”

Biden, 78, arrived at Pennsylvania Hospital Saturday morning at around 11:20 a.m. and left the hospital’s Pine Building about an hour later. The president-elect suffered hairline fractures in his midfoot two weeks prior while playing with one of his dogs.

“Weight-bearing CT results were very encouraging,” said Dr. O’Connor after the appointment. “The small fracture in the intermediate cuneiform is barely detectable and the small fracture in the lateral cuneiform is healing as expected. No more extensive injury was identified.”

Initial X-Rays did not show any obvious fracture, but a follow-up CT scan confirmed a small hairline fracture in his midfoot.

Read more about diagnosing hairline fractures with weight bearing CT here.

President-elect Biden suffered a small fracture two weeks ago while playing with one of his dogs. Initial X-Rays did not show any obvious fracture, but a follow-up CT scan confirmed a small hairline fracture in his midfoot.

“A weight-bearing CT scan has all the benefits of a standard CT scan with the additional advantages of revealing the stability of the midfoot,” said Dr. Steven Neufeld, MD, an orthopedic surgeon in Virginia. “Weight bearing CT scans can reveal any subluxation/dislocation (abnormal positioning) of the involved joints. MRI studies can create better images of soft tissues, but are but not required to diagnose a Lisfranc injury. ”

A Lisfranc injury is any injury to the midfoot. Lisfranc injures are commonly mistaken for a simple foot sprain, especially if the injury is a result of a simple twist or fall. However, bones in the midfoot may be fractured or the ligaments that hold them together may be torn. The severity can vary from simple to complex, may take many months to heal, and may require surgery to treat. Subtle Lisfranc injuries remain a challenge to diagnose.

“With weight bearing CT imaging ,’you can solve that Lisfranc case no one else can,” said Dr. Gary Briskin, DPM, a podiatrist in California. “It opens up the midfoot, which historically has been a problem for us.”

Weight bearing CT imaging was invented in 2011 just miles from where Biden got his scan by Pennsylvania-based company CurveBeam researches, designs and manufactures its weight bearing CT systems in the heart of Montgomery County.

The systems have been installed in prestigious hospitals such as Hospital for Special Surgery in New York City, N.Y. and Mayo Clinics. They’ve helped countless patients with foot, ankle and knee conditions get answers to why they are in pain.

CT imaging uses X-Ray technology to provide a three-dimensional picture of the bones and joints. Until the introduction of weight bearing CT systems, patients could only get a CT scan while lying down. The “weight bearing” view is critical for orthopedic surgeons when assessing the knees, feet and ankles, as bone and joint alignment changes when the patient is standing.

“When I first saw the news that the president-elect hurt his foot, I hoped he would be prescribed a weight bearing CT scan to have the most accurate diagnosis,” said CurveBeam President & CEO Arun Singh. “To see our technology recognized on the national stage by Biden’s physician was a milestone moment, and we hope it results in increased awareness of the modality in orthopedics and radiology, so all patients can benefit from it.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512